Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome. | Cell Rep Med | 2023 | 37148878 | PubTator, text mining | PubMed |
| Bioinformatics analysis of key candidate genes and pathways in Chinese patients with keratoconus. | Exp Eye Res | 2023 | 37116607 | PubTator, text mining | PubMed |
| Coexistence of junctional epidermolysis bullosa, autosomal recessive deafness type 57, and Angelman syndrome: A case report. | Clin Case Rep | 2023 | 37113642 | PubTator, text mining | PubMed |
| Altered Glycosylation in Progression and Management of Bladder Cancer. | Molecules | 2023 | 37110670 | PubTator, text mining | PubMed |
| Characterization of Porcine Ocular Surface Epithelial Microenvironment. | Int J Mol Sci | 2023 | 37108705 | PubTator, text mining | PubMed |
| Understanding Nephrotic Syndrome Using Kidney Transcriptome Profiling and Computational Studies. | Kidney360 | 2023 | 37103957 | PubTator, text mining | PubMed |
| Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer. | Front Med (Lausanne) | 2023 | 37089590 | PubTator, text mining | PubMed |
| Convection and extracellular matrix binding control interstitial transport of extracellular vesicles. | J Extracell Vesicles | 2023 | 37073802 | PubTator, text mining | PubMed |
| A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia. | Front Oncol | 2023 | 37064135 | PubTator, text mining | PubMed |
| In mitosis integrins reduce adhesion to extracellular matrix and strengthen adhesion to adjacent cells. | Nat Commun | 2023 | 37059721 | PubTator, text mining | PubMed |
| Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. | J Clin Med | 2023 | 37048731 | PubTator, text mining | PubMed |
| The role of integrin family in bone metabolism and tumor bone metastasis. | Cell Death Discov | 2023 | 37037822 | PubTator, text mining | PubMed |
| Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS. | ACS Omega | 2023 | 37033807 | PubTator, text mining | PubMed |
| RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma. | Thorac Cancer | 2023 | 37021520 | PubTator, text mining | PubMed |
| Mechanosensing via a GpIIb/Src/14-3-3ζ axis critically regulates platelet migration in vascular inflammation. | Blood | 2023 | 37018659 | PubTator, text mining | PubMed |
| Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner. | Cell Oncol (Dordr) | 2023 | 37014551 | PubTator, text mining | PubMed |
| Prognostic value and multifaceted roles of tetraspanin CD9 in cancer. | Front Oncol | 2023 | 37007105 | PubTator, text mining | PubMed |
| Aberrant glycosylation of α3 integrins as diagnostic markers in epithelial ovarian cancer. | Clin Chim Acta | 2023 | 37003518 | PubTator, text mining | PubMed |
Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4. | Cell Oncol (Dordr) | 2023 | 36995683 | PubTator, text mining | PubMed |
| Quantitative Proteomics for the Identification of Differentially Expressed Proteins in the Extracellular Vesicles of Cervical Cancer Cells. | Viruses | 2023 | 36992411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=18